There’s a new health innovation law firm in town! Rebecca Gwilt & Kaitlyn O’Connor have started Elevare Law to help health tech companies. We spent a little time talking about the new firm and who it’s going to work with, and a lot about the different legal and regulatory challenges facing digital health companies. Deep…
Aldeyra said the FDA did not ask for another clinical trial for reproxalap in dry eye disease, but the drug’s mixed record in clinical testing warrants exploration about the reasons for failure, which could identify the appropriate patients for the eye drop. AbbVie holds an option to collaborate on commercialization of reproxalap. The post ‘Lack…
Documentation gaps can quietly undermine everything from how your organization is publicly rated, to how they are reimbursed, to how payers evaluate your performance, leading to weaker negotiating power, and decreased ability to recruit top talent or attract patients. The post If the Record Doesn’t Reflect the Risk, the Rating Won’t Reflect the Care appeared…
By STEVEN ZECOLA Artificial intelligence (“AI”) has taken root in the field of drug discovery and development and already has shown signs of running past the traditional model of doing research. Congress should take note of these rapid changes and: 1) direct the Department of Health and Human Services (“HHS”) to phase down the government’s…
Daffodil’s Series A round was led by Flare Capital Partners, with participation from LRVHealth and Maverick Ventures. The post Daffodil Health Secures $16.3M for Health Plan Administration Platform appeared first on MedCity News.
While this kind of innovation and change can be challenging and is often a significant investment, it represents a powerful combination that can benefit individuals, healthcare professionals, and laboratories. The post Two Imperatives for the Future of Diagnostics: Adaptability and Digitalization to Unlock the Potential of AI appeared first on MedCity News.
Organizations can take steps now, in the early months of the program, to position themselves for success by evaluating past performance, identifying opportunities for improvement, and implementing episode-driven clinical and operational workflows. The post TEAM is Here, and Hospitals Are Running Out of Time to Prepare appeared first on MedCity News.
Compass Healthcare has been named one of Training Magazine’s MVP Award winners, a recognition that honors leading organizations for excellence in employer-sponsored training and development programs. “We are honored to be recognized again this year,” said Jennifer Klach, Director of Learning and Development with Compass Healthcare. “At the heart of our organization is a deep commitment to our people – it’s one of our core values. We invest…
Neurocrine Biosciences’ Crenessity is now FDA approved for treating classic congenital adrenal hyperplasia (CAH), a rare and potentially fatal endocrine disorder. The approval comes with a priority review voucher, which Neurocrine could sell for around $150 million. The post Neurocrine Lands FDA Nod for First New Treatment in Decades for Rare Endocrine Disorder appeared first…